Disruptive Innovation in Genomics
Genome Canada has recently launched the 2015 Disruptive Innovation in Genomics Competition, a two-phase, $15-million initiative.
The major objective of this RFA is to support the development of disruptive innovation in the field of genomics, which for the purpose of this RFA is defined as a new genomics-based technology or the application of an existing technology from another field, applied to the field of genomics, that is truly transformative in that it has the potential to either displace an existing technology, disrupt an existing market or create a new market. A disruptive innovation offers the capability to do things not previously possible and is not an incremental improvement of an existing technology.
It is widely acknowledged that so-called “disruptive” technologies or innovation can entail complex economic and social changes, and therefore represent a potentially rich topic for social scientists and humanities scholars. Rather than requiring applicants to include a GE3LS research component in their projects, it is expected that a more diverse exploration of the societal implications of genomic applications characterized as “disruptive” could be carried out through a parallel program directly targeted at social sciences and humanities researchers. In this regard, Genome Canada and the Social Sciences and Humanities Research Council (SSHRC) have signed a joint initiative agreement to jointly support social sciences and humanities research and related activities pertaining to genomics, with one of the first initiatives focusing on societal implications of disruptive innovation in genomics. This initiative, led by SSHRC, is also underway now.
For more information, please contact Genome Atlantic's Director of Business Development, Andy Stone